Production & Manufacturing

Aspen plans to take over Merck active pharmaceutical ingredient manufacturing plant

PBR Staff Writer Published 06 February 2013

South Africa-based Aspen Pharmacare is considering buying active pharmaceutical ingredients (API) manufacturing plant in Netherlands from Merck's MSD unit.

In case reaching a final agreement, API operations are expected to remain in Oss while staff supporting the operations transfer with the business.

No specific details are finalized. The specifics will be subject to discussion and alignment with the Oss Works Council and Trade Union, according to MSD.

Aspen is owned in part by GlaxoSmithKline.